Researchers from AMRA will present an abstract at the 60th annual European Association for the Study of Diabetes Meeting that emphasizes the link between adverse muscle composition and all-cause mortality in Type II Diabetes
Medical Research
Recent AMRA Medical Findings Presented at the 2024 ERA Congress Link Adverse Muscle Composition to Mortality in CKD
AMRA expands footprint in kidney disease research with updated results from a study exploring various biomarkers’ potential in characterizing muscle composition’s role in chronic kidney disease progression and identifying at-risk patients
New AMRA Medical Research Shows Poor Muscle Health Predicts Mortality in Obesity
Significant findings from a recent AMRA imaging analysis study, which were presented last week at the 2024 European Congress on Obesity, glean insight into the role of adverse muscle composition in mortality risk in obesity
AMRA Medical’s Muscle Composition Analysis Used to Evaluate the Effect of Liraglutide Treatment in Obesity
Results from a randomized, double-blind trial in diabetes-free adults living with obesity and high cardiovascular disease risk showed that liraglutide was associated with a reduction in both muscle fat infiltration and prevalence of adverse muscle composition when compared to placebo
Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study
The comprehensive ACCESS-ESLD study aims to validate novel biomarkers and imaging techniques for screening of hepatocellular carcinoma and sarcopenia in liver cirrhosis patients using a rapid, non-invasive clinical surveillance methodology, powered by AMRA’s MRI-based body composition technology
AMRA Medical’s Innovative Fat Z-Score Biomarkers Show Tirzepatide Treatment is Associated with a Potential Targeted Effect on Visceral Fat and Liver Fat
Exploratory analysis from the SURPASS-3 MRI study shows significant reduction of both visceral- and liver fat z-scores, and a shift towards a…